Despite these limitations, our results suggest that mitochondrial transcription factor A, encoded by the nuclear TFAM gene, may play an important role in head and neck cancer patient survival and could potentially serve as a prognostic survival biomarker. Here, TFAM is linked to head and neck cancer.